Furthermore, minimizes nonfatal stroke by about 16%, hospitalization for heart failure (HF) by about 10%, all-cause fatality by 12%, and broad composite renal outcomes by 17%
Over time, minor adjustments such as choosing the stairs or cooking in bulk can accumulate to major victories
In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
Instead of precision targeting one receptor system, it casts a wide net across three interconnected metabolic systems